This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
TSMC: the consolidated revenue in April was about NT $172.561 billion, a year-on-year increase of 55%
China coal transportation and Marketing Association: continue to ensure the supply and price of coal and maintain normal coal production
Lian Ping: China's economic growth is likely to exceed expectations in 2022, and it is expected to achieve a growth rate of about 5.7%
Goldman Sachs: the average oil demand in 2022 and 2023 will reach a record high
Diamond stocks fell in early trading
Zhang Kun's four funds decreased their positions in the second quarter by allocating Wuliangye to Guizhou Maotai
Yanghe shares: plan to launch the first phase of core backbone shareholding plan with an amount of 1 billion yuan
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
Baijiu plate opened lower
Yanghe Brewery Hires Yin Qiuming and Li Yuling as Vice Presidents
The First Move of the U.S. Postal Service on Cross-Border E-commerce After Trump
Feb 21, 2025 08:19 PM
Shanghai and Shenzhen: The Dual-City Landscape and Corporate Power
Jan 09, 2025 03:35 PM